Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on April 7, 2008

Hypertension. 2008
Published online before print April 7, 2008, doi: 10.1161/HYPERTENSIONAHA.107.103804
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/6/1578    most recent
HYPERTENSIONAHA.107.103804v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow patientINFORMation
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Deo, R.
Right arrow Articles by Shlipak, M. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deo, R.
Right arrow Articles by Shlipak, M. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiac Arrest
*Kidney Diseases
Hazardous Substances DB
*ESTROGENIC SUBSTANCES, CONJUGATED
Related Collections
Right arrow Epidemiology
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Congestive

Submitted on October 21, 2007
Revised on November 15, 2007

Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease

Rajat Deo; Feng Lin; Eric Vittinghoff; Zian H. Tseng; Stephen B. Hulley; and Michael G. Shlipak*

From the Division of Cardiology (R.D.), Johns Hopkins Hospital, Baltimore, Md; General Internal Medicine Section (M.G.S.), Veterans Affairs Medical Center, and Departments of Medicine, Epidemiology, and Biostatistics (F.L., E.V., S.B.H., M.G.S.), and the Division of Cardiology (Z.H.T.), University of California School of Medicine, San Francisco.

* To whom correspondence should be addressed. E-mail: Michael.Shlipak{at}ucsf.edu.

Abstract—We evaluated the association between kidney dysfunction and sudden cardiac death risk among ambulatory women with coronary heart disease. The Heart and Estrogen Replacement Study evaluated the effects of hormone treatment on cardiovascular events among 2763 postmenopausal women with coronary heart disease. Kidney dysfunction was categorized by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation. Multivariate proportional hazards models were used to adjust for cardiovascular risk factors, congestive heart failure, and myocardial infarction. At baseline, 37% (n=1027) had an eGFR of >60 mL/min, 54% (n=1503) had an eGFR of 40 to 60 mL/min, and 8% (n=230) had an eGFR of <40 mL/min. During the 6.8-year follow-up period, there were 136 adjudicated sudden cardiac deaths. The rate of sudden cardiac death was higher in those with lower kidney function (0.5% per year among those with an eGFR >60; 0.6% per year with an eGFR between 40 and 60; and 1.7% per year with an eGFR <40 mL/min; P for trend <0.001). After multivariate analysis with baseline risk factors, eGFR at 40 to 60 mL/min was not a significant predictor, but eGFR at <40 mL/min remained strongly associated with sudden cardiac death (hazard ratio: 3.2; 95% CI: 1.9 to 5.3); adjustment for incident congestive heart failure and myocardial infarction during follow-up diminished this association (hazard ratio: 2.3; 95% CI: 1.3 to 3.9), suggesting that congestive heart failure and myocardial infarction mediated only part of the association between kidney dysfunction and sudden cardiac death. Advanced kidney dysfunction is an independent predictor of sudden cardiac death among women with coronary heart disease.


Key words: kidney dysfunction • women • sudden cardiac death


Find additional patient-related information at:

Read a summary of this article at americanheart.org